Krakchemia Statistics
Total Valuation
Krakchemia has a market cap or net worth of PLN 10.44 million. The enterprise value is 14.01 million.
Market Cap | 10.44M |
Enterprise Value | 14.01M |
Important Dates
The next estimated earnings date is Friday, April 25, 2025.
Earnings Date | Apr 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Krakchemia has 9.00 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 9.00M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 60.44% |
Owned by Institutions (%) | n/a |
Float | 3.56M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.21 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.06 |
EV / Sales | 0.29 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15
Current Ratio | 0.15 |
Quick Ratio | 0.10 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -0.85 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -15.84% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 10.31% |
Revenue Per Employee | 1.43M |
Profits Per Employee | -389,882 |
Employee Count | 34 |
Asset Turnover | 2.15 |
Inventory Turnover | 11.46 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +207.29% in the last 52 weeks. The beta is 0.13, so Krakchemia's price volatility has been lower than the market average.
Beta (5Y) | 0.13 |
52-Week Price Change | +207.29% |
50-Day Moving Average | 1.18 |
200-Day Moving Average | 0.78 |
Relative Strength Index (RSI) | 47.37 |
Average Volume (20 Days) | 91,842 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Krakchemia had revenue of PLN 48.72 million and -13.26 million in losses. Loss per share was -1.47.
Revenue | 48.72M |
Gross Profit | 5.44M |
Operating Income | -5.75M |
Pretax Income | -13.33M |
Net Income | -13.26M |
EBITDA | -4.78M |
EBIT | -5.75M |
Loss Per Share | -1.47 |
Balance Sheet
The company has 332,000 in cash and 3.90 million in debt, giving a net cash position of -3.57 million or -0.40 per share.
Cash & Cash Equivalents | 332,000 |
Total Debt | 3.90M |
Net Cash | -3.57M |
Net Cash Per Share | -0.40 |
Equity (Book Value) | -56.76M |
Book Value Per Share | -6.31 |
Working Capital | -63.25M |
Cash Flow
Operating Cash Flow | 186,000 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 11.16%, with operating and profit margins of -11.81% and -27.21%.
Gross Margin | 11.16% |
Operating Margin | -11.81% |
Pretax Margin | -27.35% |
Profit Margin | -27.21% |
EBITDA Margin | -9.82% |
EBIT Margin | -11.81% |
FCF Margin | n/a |
Dividends & Yields
Krakchemia does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -126.97% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Krakchemia has an Altman Z-Score of -8.32. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -8.32 |
Piotroski F-Score | n/a |